CARLO RIZZUTO

Profile

First Name

: CARLO

Middle Name

:

Last Name

: RIZZUTO

Related Companies
Titles
Company Name
Related People
DIRECTOR
VENATORX PHARMACEUTICALS, INC.
CHRISTOPHER J BURNS, CHRISTOPHER J. BURNS, SHELLEY CHU, MICHAEL DIEM, EZRA FELKER, TIMOTHY HAINES, MARTIN HEIDECKER, TIM HENKEL, TIMOTHY J. HENKEL, TOMAS HEYMAN, ANTHONY MEEHAN, VINCENT J. MILANO, JAMES MURPHY, SERGEI PETUKHOV, DANIEL C PEVEAR, DANIEL C. PEVEAR, LUIGI XERRI
EXECUTIVE OFFICER, DIRECTOR
QUENTIS THERAPEUTICS, INC.
MICHAEL ABERMAN, MICHAEL FOLEY, MICHAEL FOLEY, PH.D., B. FINN PETER, AMY SCHULMAN, JOSEPH P. VACCA, PH.D
DIRECTOR
PANDION THERAPEUTICS, INC.
ANTHONY COYLE, ALAN CRANE, VIKAS GOYAL, MITCHELL MUTZ, JO VINEY
DIRECTOR
PANDION THERAPEUTICS HOLDCO LLC
DANIEL BECKER, JILL CARROLL, ALAN L. CRANE, DONALD FRAIL, CHRISTOPHER FUGLESANG, VIKAS GOYAL, RAHUL KAKKAR, MITCHELL MUTZ, NANCY STAGLIANO, JO VINEY
DIRECTOR
GRAPHITE BIO, INC.
ABRAHAM BASSAN, JEREL DAVIS, PHILIP GUTRY, JOE JIMENEZ, PERRY KARSEN, JOSH LEHRER, MATTHEW PORTEUS, MARIA GRAZIA RONCAROLO, KATHERINE STULTZ
DIRECTOR
CENTURY THERAPEUTICS, INC.
TOSHIKAZU BAN, CYNTHIA BUTITTA, DOUGLAS CARR, ELI CASDIN, JUERGEN ECKHARDT, OSVALDO FLORES, PH.D., JOSEPH JIMENEZ
DIRECTOR
858 THERAPEUTICS, INC.
ALI BEHBAHANI, KATHERINE BELL-MCGUINN, BRADLEY J. BOLZON, JANE HUANG, STAFFORD JEFFREY, MONAL MEHTA, CLARE OZAWA, JEFFREY A. STAFFORD, JAMES VEAL
DIRECTOR
JNANA THERAPEUTICS INC.
JOEL BARRISH, CAROLINE STARK BEER, BRIAN M. CALI, ANNIE C. CHEN, MATTHEW HAMMOND, KEVIN J. KINSELLA, JOANNE D. KOTZ, TERRANCE G. MCGUIRE, DONALD W. NICHOLSON, DOUGLAS W. PAGAN, RONALD C. RENAUD, JR., STUART SCHREIBER, GEORGE VRATSANOS
DIRECTOR
NEXO THERAPEUTICS, INC.
ALI BEHBAHANI, MICHAEL KIM, ANDREW PHILLIPS
EXECUTIVE OFFICER
VERSANT VOYAGEURS III, L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, CLARE OZAWA, N/A VERSANT VOYAGEURS III GP (CANADA), LLC, N/A VERSANT VOYAGEURS III GP, L.P., N/A VERSANT VOYAGEURS III GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VOYAGEURS III (CANADA), L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, CLARE OZAWA, N/A VERSANT VOYAGEURS III GP (CANADA), LLC, N/A VERSANT VOYAGEURS III GP, L.P., N/A VERSANT VOYAGEURS III GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VANTAGE III, L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, CLARE OZAWA, N/A VERSANT VANTAGE III GP (CANADA), LLC, N/A VERSANT VANTAGE III GP, L.P., N/A VERSANT VANTAGE III GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VANTAGE III (CANADA), L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, CLARE OZAWA, N/A VERSANT VANTAGE III GP (CANADA), LLC, N/A VERSANT VANTAGE III GP, L.P., N/A VERSANT VANTAGE III GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VENTURE CAPITAL IX, L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, CLARE OZAWA, N/A VERSANT VENTURES IX GP (CANADA), LLC, N/A VERSANT VENTURES IX GP, L.P., N/A VERSANT VENTURES IX GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VENTURE CAPITAL IX (CANADA), L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, CLARE OZAWA, N/A VERSANT VENTURES IX GP (CANADA), LLC, N/A VERSANT VENTURES IX GP, L.P., N/A VERSANT VENTURES IX GP-GP, LLC, THOMAS WOIWODE
DIRECTOR
PEP2TANGO THERAPEUTICS, INC.
SOUMITRA GHOSH, MICKEY KIM, CRISTINA RONDINONE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2022-11-15 
2025-09-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-15 
2024-11-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-09-20 
2024-09-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-15 
2024-01-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-02 
2023-04-07
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-10-12 
2023-04-07
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-10-12 
2023-04-07
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-10-12 
2023-04-07
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-10-12 
2023-04-07
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-10-12 
2023-04-07
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-10-12 
2022-11-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-15 
2022-11-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-02 
2021-08-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-12 
2021-05-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-04 
2021-03-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-11 
2021-03-15
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-25 
2020-04-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-23 
2018-11-05
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-13 
2018-03-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-15 
2018-01-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-05 
2017-07-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-13